Correlation Between Replimune and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Replimune and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Replimune and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Alnylam Pharmaceuticals.
Diversification Opportunities for Replimune and Alnylam Pharmaceuticals
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Replimune and Alnylam is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Replimune i.e., Replimune and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between Replimune and Alnylam Pharmaceuticals
Given the investment horizon of 90 days Replimune Group is expected to generate 1.6 times more return on investment than Alnylam Pharmaceuticals. However, Replimune is 1.6 times more volatile than Alnylam Pharmaceuticals. It trades about 0.17 of its potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about 0.25 per unit of risk. If you would invest 1,211 in Replimune Group on November 1, 2024 and sell it today you would earn a total of 196.00 from holding Replimune Group or generate 16.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Replimune Group vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| Replimune Group |
| Alnylam Pharmaceuticals |
Replimune and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Replimune and Alnylam Pharmaceuticals
The main advantage of trading using opposite Replimune and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.| Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |